Please enter the requested information for the discussion leader and discussion topic. Round Tables will be presented onsite at the conference. There will be no virtual Round Tables at this time. All round table leaders must be registered for the DIA/FDA Oligonucleotide-based Therapeutics Conference.
Please save your own copy of your title and abstract as this simple form has no way to automatically mail it to you.
Questions with asterisks are required.
The submission deadline is March 4, 2022.
Notification letters are anticipated to be sent the week of March 21, 2022.